BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16109615)

  • 21. Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia.
    Bartholomae S; Gruhn B; Debatin KM; Zimmermann M; Creutzig U; Reinhardt D; Steinbach D
    Pediatr Blood Cancer; 2016 Feb; 63(2):242-7. PubMed ID: 26512967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps.
    Di Giacomo S; Briz O; Monte MJ; Sanchez-Vicente L; Abete L; Lozano E; Mazzanti G; Di Sotto A; Marin JJG
    Arch Toxicol; 2019 Mar; 93(3):623-634. PubMed ID: 30659321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP-Binding Cassette transporters' gene expression in pediatric patients with acute leukemia; a comprehensive analysis of published reports through PubMed search engine.
    Mehrvar N; Akbari ME; Rezvany MR; Abolghasemi H; Saberynejad J; Mehrvar A; Faranoush M; Keramatinia AA; Shekarriz-Foumani R; Movafagh A
    Cell Mol Biol (Noisy-le-grand); 2019 Feb; 65(2):7-13. PubMed ID: 30860475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.
    Young LC; Campling BG; Voskoglou-Nomikos T; Cole SP; Deeley RG; Gerlach JH
    Clin Cancer Res; 1999 Mar; 5(3):673-80. PubMed ID: 10100721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
    van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ
    Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines.
    Bierman WF; Scheffer GL; Schoonderwoerd A; Jansen G; van Agtmael MA; Danner SA; Scheper RJ
    J Antimicrob Chemother; 2010 Aug; 65(8):1672-80. PubMed ID: 20551216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
    Fazlina N; Maha A; Jamal R; Zarina AL; Cheong SK; Hamidah H; Ainoon O; Zulkifli SZ; Hamidah NH
    Hematology; 2007 Feb; 12(1):33-7. PubMed ID: 17364990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.
    Rahgozar S; Moafi A; Abedi M; Entezar-E-Ghaem M; Moshtaghian J; Ghaedi K; Esmaeili A; Montazeri F
    Cancer Biol Ther; 2014 Jan; 15(1):35-41. PubMed ID: 24145140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of breast cancer resistance protein in acute lymphoblastic leukemia.
    Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG
    Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of development, HIV infection, and antiretroviral therapies on the gene expression profiles of ABC transporters in human lymphocytes.
    Giraud C; Manceau S; Declèves X; Goffinet F; Morini JP; Chappuy H; Batteux F; Chouzenoux S; Yousif S; Scherrmann JM; Blanche S; Tréluyer JM
    J Clin Pharmacol; 2010 Feb; 50(2):226-30. PubMed ID: 19837908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia.
    Efferth T; Gillet JP; Sauerbrey A; Zintl F; Bertholet V; de Longueville F; Remacle J; Steinbach D
    Mol Cancer Ther; 2006 Aug; 5(8):1986-94. PubMed ID: 16928819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.
    Kaspers GJ; Kardos G; Pieters R; Van Zantwijk CH; Klumper E; Hählen K; de Waal FC; van Wering ER; Veerman AJ
    Leukemia; 1994 Jul; 8(7):1224-9. PubMed ID: 8035616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
    Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Balwierz W; Juraszewska E; Matysiak M; Malinowska I; Stanczak E; Sońta-Jakimczyk D; Szczepanski T; Wachowiak J; Konatkowska B; Balcerska A; Ploszynska A; Kowalczyk J; Stefaniak J; Badowska W; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M
    Neoplasma; 2005; 52(1):74-8. PubMed ID: 15739031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia.
    Steinbach D; Sell W; Voigt A; Hermann J; Zintl F; Sauerbrey A
    Leukemia; 2002 Aug; 16(8):1443-7. PubMed ID: 12145683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.
    Taipalensuu J; Törnblom H; Lindberg G; Einarsson C; Sjöqvist F; Melhus H; Garberg P; Sjöström B; Lundgren B; Artursson P
    J Pharmacol Exp Ther; 2001 Oct; 299(1):164-70. PubMed ID: 11561076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
    Pieters R; den Boer ML; Durian M; Janka G; Schmiegelow K; Kaspers GJ; van Wering ER; Veerman AJ
    Leukemia; 1998 Sep; 12(9):1344-8. PubMed ID: 9737681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.